AQP4 and myeloid sarcoma: We used seventeen purified IgGs samples of the serum: five of healthy volunteers (negative control), four MS, and eight NMOSD AQP4-Ab-negative patient samples to compare with adhesion forces for NMOSD AQP4-Ab-positive patients.